-+ 0.00%
-+ 0.00%
-+ 0.00%

ACUMEN PHARMACEUTICALS SHARES EXTEND LOSSES AFTER CO'S ALZHEIMER'S DRUG MISSES PRIMARY ENDPOINT IN MID-STAGE TRIAL; LAST DOWN 85.9%

Reuters·10/30/2026 13:35:34

Please log in to view news